Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
92,740
-
Shares change
-
-14,699
-
Total reported value, excl. options
-
$4,307,328
-
Value change
-
-$708,738
-
Number of buys
-
1
-
Number of sells
-
-5
-
Price
-
$46.45
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q2 2023
7 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q2 2023.
NOVOZYMES A S DKK 2.0 - COM has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92,740 shares
.
Largest 7 shareholders include SOMERVILLE KURT F (30,088 shares), Broderick Brian C (27,509 shares), PUZO MICHAEL J (13,120 shares), Kidder Stephen W (10,100 shares), Notis-McConarty Edward (6,200 shares), Hemenway Trust Co LLC (5,723 shares), and Delaney Dennis R (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.